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Abstract 
 
  Asthma has increased by 2.0 and 2.3 times in obese children and adults. Obesity is also associated with 
inflammation and control of asthma which can be mediated by increased respiratory tract inflammation 
and hyper responsive respiratory tract. Systematic Review and meta-analysis method by using PRISMA-
P 2015 were used in this study. We were collected through searching electronic literature from 
Sciencedirect, Researchgate and Google Scholar. Based on the literature study method conducted in 25 
related journals, it can be summarized that there are similar perceptions of the results of analysis where 
asthma is closely related to obesity due to several main factors. Obesity impact as an important role in the 
development of respiratory diseases. Asthma and obesity are complex and multifactorial which greatly 
affects health conditions, where the body's internal factors and environment play an important role in the 
health and quality of life of the community. Weight loss can improve lung function, reduce the possibility 
of asthma, and improve overall health status. Appropriate treatment techniques for individuals suffering 
from acid obesity can be done through simvastatin therapy and increased body adiponectin. 
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1. Introduction 
  
In recent years, the mechanism underlying the relationship between obesity and asthma is widely 
investigated. The prevalence of obesity has increase, about 65% of the population in the US is classified 
as overweight or obese. Obesity is a known risk factor for causing many diseases in humans, including 
asthma, cardiovascular disease, diabetes, and certain types of cancer [X. Song,B. Li et al & L. 
guelliminault. 2019]. 
 
Asthma is a type of long-term or chronic disease in the respiratory tract that is characterized by 
inflammation and narrowing of the airways which causes tightness or difficulty breathing. In addition to 
difficulty breathing, people with asthma can also experience other symptoms such as chest pain, and 
coughing [L. guelliminault. 2019, J.A. Lucas et al 2018].  
 
Based on several studies in Asia, the prevalence of asthma varies from 0.7% - 11.9%. The prevalence of 
asthma in China is reported 0.7 - 3.8%, Korea 3.6 - 6.8%, Iran 1.4 - 6.1%, India 2.4 - 3.5%, and the 
prevalence of asthma in South and Southeast Asia, 2.4 - 3.9%. Whereas in Indonesia, an increase in asthma 
prevalence from 4% in 2007 to 4.5% in 2013. West Java Province has a higher asthma prevalence compared 
to the national asthma prevalence of 5% [Riskesdas, 2013] 
 
The National Health and Nutrition Examination Survey (NHANES) data shows that one in three asthma 
patients is obese and the prevalence of obesity among current asthma subjects has increased from 21.3% 
to 32.8% [F. Rusconi, M. Popovic 2017]. An EAACI meta-analysis showed that almost twice as much 
weight gain triggered the possibility of asthma. 
 
In our analysis of the 2013-2014 National Health and Nutrition Examination Survey (NHANES), a total 
of 1,375 adult male participants were involved. Among them, 12.65% had asthma [Y. Tomita et al. 2019]. 
Several studies have shown that asthma is a risk factor for obesity that is positively correlated with BMI. 
Regarding the BMI threshold for diagnosing an increased risk of asthma, previous studies from Western 
countries have shown an increase in the prevalence of asthma with a BMI higher than 25 kg / m or 30 kg / 
m [Y. Tomita et al. 2019, M.To, K. Haruki, 2018, R barros 2017]. 
 
Generally the respiratory system of obese people has a high respiratory rate and low tidal volume which 
increases the risk of asthma and the severity of asthma. In addition, many studies have shown that 
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obstruction of obesity- induced lipid metabolism and changes in endocrine function of adipose tissue 
worsen the condition of asthma [ L. Zhu, X. Chen 2019]. 
 
Cross-sectional studies in children and adults have shown that plasma leptin levels are higher in asthma 
patients [C.T. Juel, C.S. Ulrik, 2013]. Increased levels of leptin are the physiopathological basis of 
metabolic disorders and systemic inflammatory reactions [Gibeon D, et al. 2013] Leptin is positively 
correlated with total body fat mass and may also play an important role in the pathogenesis of asthma. 
Leptin is a fat originally identified as a hormone released by adipocytes and positively correlated with total 
body fat mass [Ostrom NK, et al. 2013]. 
 
Correlation analysis shows that there is a positive correlation between the percentage of neutrophils and 
serum leptin / cholesterol levels, which suggests that the efficacy of simvastatin therapy in asthma obesity 
may be related to an increase in dyslipidemia and a decrease in leptin levels [Abd El-Kader MS, et al. 2013, 
Chen Z, et al. 2017]. Cumulative studies have shown that the protein hormone adiponectin can produce 
beneficial anti-inflammatory effects [Westergren T, et al. 2016]. Thus, the findings of this study indicate 
that adiponectin can be used as a new pharmacological intermediary for treating asthma in obese 
individuals [Westergren T, et al. 2016]. Based on the description above, the author would like to know a 
review of obesity with asthma and the collection of research on interventions carried out for cases of obesity 
against asthma. In the study of obesity with asthma there has been a lot of literature that discusses it for 
conversion studies in cases of obesity against asthma not yet seen in Indonesia, so this needs to be used as 
a review journal to obtain benefits and research for the intervention of obesity cases against asthma. 
 
2. Method 
 
Search Strategy 
In this study we conduct a writing system using the PRISMA method (Preferred Reporting Items for 
Systematic Reviews and Meta-analyzers). We search three source databases, namely Sciencedirect, 
Researchgate and Google Shcolar to take peer- reviewed publications from publications relevant to the 
titles we adopted. Database search based on publications from 2013 to 2019. The search term covers 4 
aspects, namely asthma, obesity, breathing, medication and exercise. 
 
Eligibility Criteria 
This study reviews the problem of asthma related to obesity. In the first stage, we classified the titles and 
abstract studies that will be used as the study literature. There are limitations to the reference grouping 
including the language in which we only refer to the literature with the study of English and Indonesian; 
then the country of origin of study where we only take from studies in the Asia region and Europe only; 
and finally the factors associated with asthma are narrowed by only seeing references related to asthma 
against obesity. The exclusion criteria for the study are outside the boundaries of the above compilation 
that are irrelevant. 
 
Data Extraction 
The literature data is sought and summarized for 2 weeks starting from April 1, 2019 according to the 
scope of this study. Compilation was carried out independently by two authors. The main section of the 
review study contains titles, abstracts, and discussions filtered to identify studies that include relevance for 
reference. Reviewing the contents of reference studies is also done carefully so that it is easy to find the 
essence of the related study. The criteria for grouping this study will lead us to conclusions. The research 
data from the literature are summarized in the form of tables and pictures of structured study results and 
given an explanation according to the results of the study. The conclusion in this study is that we combine 
it based on the results of the reference conclusions.    
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Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and 
Meta-analyses) Method 
3. Result 
 
Quantity of systematic reviews 
Based on the stages of the PRISMA method used, we looked for 135 records identified from 3 bases 
(Sciencedirect, Researchgate and Google Shcolar) and obtained 74 single quotes, then manually selected 
for possible entry as a related reference. After filtering 61 literature, 13 literature were released because 
there was no relevance. Furthermore, there are 45 remaining records / literature assessed for eligibility. 
The literature reviews the relationship and interrelated factors between obesity and asthma in several 
regions and the range of sufferers, while also examining matters related to treatment techniques that can 
be done. From the results of the feasibility of the study, only 20 literature were found that had been 
observed meeting the topic of the study. 
 
Korelation Between Obesity Against to Asthma 
From the 20 literature studies reviewed showed that 10 references mention obesity is a known risk factor 
for causing many diseases in humans, including asthma. Complications of obesity are very relevant to 
chronic inflammation (asthma). 5 references state that the respiratory system of obese people has a high 
respiratory rate and low tidal volume which increases the risk of asthma and the severity of asthma. In 
addition, 3 study references concluded that impaired obesity-induced lipid metabolism and changes in 
endocrine function of adipose tissue worsen asthma conditions, can change the efficacy of standard asthma 
drugs, which make asthma patients respond poorly to treatment. The remaining 2 other references state 
that Simvastatin and adiponectin treatment can be used as new pharmacological tools to treat asthma in 
individuals with asthma obesity. 20 These references are summarized in Table 1. 
 
Table 1. Correlation Between Obesity Against to Asthma 
No. Journal Title Database Place of 
Journal 
Journal 
Author 
Relation Between Astma 
and Obesity 
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1. Exercise induced 
bronchospasm, 
asthma control, 
and obesity 
Allergy 
Asthma 
Proceeding 
USA Ostrom NK et 
al, 2013 
Exercise-related 
respiratory symptoms 
occur more commonly in 
patients with 
not well and very poorly 
controlled asthma. 
Obesity was found more 
often in adolescents and 
adults, but not children, 
with 
asthma, which was not 
well and very poorly 
controlled 
2. Impact On 
Severity, Asthma 
Control, And 
Response To 
Therapy, Respir 
Respire Care Denmar
k 
C.T. Juel et al, 
2013 
Overweight and obesity is 
associated with poorer 
asthma control and, very 
importantly, overall 
poorer response to asthma 
therapy, compared with 
normal weight 
individuals. 
 
3. Obesity-
Associated Severe 
Asthma Represents 
a Distinct Clinical 
Phenotype 
Original 
Research 
Asthma 
(CHEST) 
England Gibeon D, 
2013 
Patients with severe 
asthma display particular 
characteristics according 
to BMI that support the 
view that obesity-
associated severe asthma 
may represent a distinct 
clinical phenotype. 
4. Body Mass Index 
As Predictor For 
Asthma: A Cohort 
Study Of 118,723 
Males And 
Females 
European 
Respiratory 
Journal 
Oslo V. Hjellvik et 
al, 2014 
Asthma incidence, as 
measured by anti-
asthmatic drug use, was 
positively related to both 
BMI and change in BMI. 
For BMI, the association 
was stronger for never-
smokers than for ex-
smokers and current 
smokers. 
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5. Linking obesity 
and asthma 
New York 
Academy of 
Sciences 
New 
York 
E. Rand 
Sutherland, 
2014 
Epidemiologic, clinical, 
and translational 
studies suggest that 
obesity increases the risk 
of developing asthma 
while also making it more 
difﬁcult 
to achieve optimal asthma 
contro 
6. Obesity increases 
airway 
hyperresponsivene
ss 
via the TNF-alpha 
pathway and 
treating obesity 
induces recovery 
Plos One South 
Korea 
J.Y. Kim et al, 
2015 
Restoring normal 
body weight is an 
appropriate strategy for 
reducing TNF-α levels, 
and controlling 
inflammation 
may help improve asthma 
severity and control in 
obesity-related asthma. 
7.  Childhood obesity 
in relation to poor 
asthma control and 
exacerbation: a 
meta-analysis 
European 
Respiratory 
Journal 
Europe Ahmadizar F 
et al, 2016 
In asthmatic children, 
obesity is associated with 
a minor increased risk of 
asthma exacerbations but 
not 
with poor asthma control. 
8. Heterogeneity of 
obesity-asthma 
association 
disentangled by 
latent class 
analysis, the 
SAPALDIA cohort 
Respiratory 
Medicine  
Switzerl
and 
Ayoung Jeong 
et al, 2017 
Obesity was positively 
associated with symptom-
presenting asthma classes 
but not with symptom-
free ones. Percent body fat 
showed the strongest 
association with the 
persistent multiple 
symptom-presenting 
asthma 
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9. The Effect of 
Obesity to the 
Occurrence of 
Asthma in Fatimah 
Islamic Hospital 
Cilacap, Indonesia 
Sainteks  Indones
ia 
Nurrizky 
haitamy,  et al 
2015 
Chi square test results also 
showed significance of 
0.002 which means there 
waseffect between obesity 
and asthma in Fatimah 
Islamic Hospital Cilacap. 
Based on this research, 
conclusion can be drawn 
that there is an effect of 
obesity to the occurrence 
of asthma in Fatimah 
Islamic Hospital Cilacap 
(p=0,002) 
10. Obesity increases 
the prevalence and 
the incidence of 
asthma and 
worsens asthma 
severity 
Clinical 
Nutrition  
Portugal R. Barros ae al, 
2017 
Obesity is associated in a 
dose dependent way with 
an increase of prevalent 
and incident asthma, and it 
seems to increase the odds 
of a more persistent and 
severe asthma phenotype 
independently of socio-
demographic 
determinants, physical 
activity, and dietary 
patterns. Study results 
provide rational for future 
lifestyle intervention 
studies for weight 
reduction in the obesity 
asthma phenotype. 
11. Treatment of obese 
asthma in a mouse 
model by 
simvastatin is 
associated with 
improving 
dyslipidemia and 
decreasing leptin 
level 
Biochemical 
and 
Biophysical 
Research 
Communicati
ons 
China W. Han et al, 
2017 
Simvastatin treatment 
reduces the levels of 
glucose, lipid, leptin and 
neutrophil percentage, 
and improves airway 
inﬂammation and 
remodeling, which can be 
as a potential therapeutic 
target used in the 
treatment of obese asthma 
in humans. Correlation 
analysis shows that there 
is positive correlation 
between neutrophil 
percentage and serum 
leptin/cholesterol level, 
which indicates that the 
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therapeutic efﬁcacy of 
simvastatin on obese 
asthma might be 
associated with improving 
dyslipidemia and 
decreasing leptin level. 
12. Efﬁcacy of an 
exercise 
intervention among 
children with 
comorbid asthma 
and obesity 
Public Health  USA J.A. Lucas  et 
al, 2018 
The mean age of this 
population (N=232) was 
11 years; 54% were male, 
64% were hispanic, and 
37% had asthma, study 
found both beneﬁcial and 
practical for obese 
children with asthma for 
losing weight and 
improving 
cardiorespiratory function 
13. Obesity-associated 
severe asthma in an 
adult Japanese 
population 
Respiratory 
investigation  
Japan Masako To et 
al, 2018 
In the female cohort, the 
annual 
exacerbation ratio and the 
percentage of frequent 
exacerbators were signiﬁ 
cantly higher in the Obese 
group compared to the 
N0n-Obese group. A 
multivariate logistic 
regression analysis 
showed that obesity was 
independently associated 
with frequent asthma 
exacerbations in the 
female cohort. 
14. Obesity and 
asthma 
Journal of 
Allergy and 
Clinical 
immunology 
Pittsbur
gh 
U. Peters at al, 
2018 
Obesity is an important 
risk factor for asthma and 
asthmamorbidity, both in 
children and adults This is 
areflection of an obese 
asthma syndrome that is 
complex 
andmultifactorial. 
Potential underlying 
mechanisms include 
ashared genetic 
component, dietary and 
nutritional 
factors,alterations in the 
gut microbiome, systemic 
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inflammation,metabolic 
abnormalities, and 
changes in lung anatomy 
andfunction 
15. Asthma alleviates 
obesity in males 
through regulating 
metabolism and 
energy expenditure 
BBA - 
Molecular 
Basis of 
Disease  
China Xiaomin Song 
et al, 2019 
Found that Body Mass 
Index (BMI) and waist 
circumference were 
signiﬁcantly lower in 
males suﬀering asthma 
and suggest asthma in 
males decreases obesity 
by improving the 
metabolism function of 
brown and subcutaneous 
adipose tissue, and 
decreasing insulin 
resistant in the liver 
16. Chronic cough and 
obesity 
Pulmonary 
Pharmacolog
y & 
Therapeutics  
  
France Laurent 
Guilleminault, 
2019 
The crucial role of obesity 
has been highlighted in 
the development and 
progression of many 
respiratory diseases, 
obesity, particularly 
abdominal obesity, may 
also be associated with 
chronic cough (CC) 
17. Obesity, but not 
metabolic 
syndrome, as a risk 
factor for late-onset 
asthma in Japanese 
women 
Allergology 
International  
Japan Yasuhiro 
Tomita et al, 
2019 
Only the obesity 
measures, not metabolic 
syndrome, were shown to 
be signiﬁcant risk factors 
for the incidence of late-
onset asthma but only in 
middle-aged Japanese 
women, and not in men 
18. Severe asthma in 
Japan 
Allergology 
International  
Japan Hiroyuki 
Nagase, 2019 
The characteristic 
phenotype of severe 
asthma in Japan seems to 
be distilled into the 
following two features: 
low incidence of obesity 
and high prevalence of 
patients with type 2 
inﬂammation. Only 5e7% 
of Japanese severe asthma 
patients had a body mass 
index (BMI) 30 kg/m and 
more than 80% of patients 
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with severe asthma 
exhibited type 2 
inﬂammation. Although 
the relationship between 
obesity and non-type 2 
inﬂammation is complex, 
the low incidence of 
obesity might explain the 
prevalence of type 2 
inﬂammation. 
19. Obesity and severe 
asthma 
Allergology 
International 
USA H Tashiro et al, 
2019 
there is  increasing 
evidence that obesity is 
causally related to asthma. 
Evidence of a role for the 
microbiome in obese 
asthma also suggests that 
greater attention to 
components of diet and 
their impact on the gut 
microbiome may 
ultimately prove useful 
for the obese asthmatic 
patient 
20 Adiponectin 
alleviates 
exacerbation of 
airway 
inﬂammation and 
oxidative 
stress in obesity-
related asthma 
mice partly 
through AMPK 
signaling 
pathway 
International 
Immunophar
macology  
 
China Lili Zhu  et al, 
2019 
Study was conclude that 
adiponectin alleviates 
exacerbation of airway 
inﬂammation and 
oxidative stress in a 
murine model of 
obesityrelated asthma 
partly through AMPK 
signaling pathway. 
 
 
4. Discussion 
 
Asthma is a chronic respiratory disease that affects around 235 million people worldwide. Asthma is 
chronic airway inflammation and is accompanied by other allergic diseases in some cases, which have a 
high incidence among children. An increasing number of epidemiological studies focus on obesity and 
asthma. The majority of them showed that asthma was positively associated with obesity [X. Song et al 
2019]. 
Obesity is defined as a weight more than 20% above the ideal. Obesity can worsen asthma conditions, and 
change the efficacy of standard asthma drugs, which make asthma patients respond poorly to 
glucocorticoid treatment [L. Zhu, X. Chen et al, 2019]. At present, a large number of epidemiological 
results indicate a link between asthma and obesity. The effect of leptin levels due to obesity, lack of 
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adiponectin levels in the body, and improper treatment techniques can be a major source of obesity-related 
asthma. 
 
Effect of Leptin Levels on Asthma Severity and the Role of the Technique for Treatment of Simvastatin 
 
Obesity and induced asthma affect lung function. Generally the respiratory system of obese people has a 
high respiratory rate and low tidal volume which increases the risk of asthma and the severity of asthma. 
In addition, many studies have shown that obesity-induced lipid metabolism (high levels of leptin) induced 
and changes in endocrine function of adipose tissue worsen asthma conditions [F. Rusconi, et al, Y. Tomita 
2019]. Moreover, an inappropriate asthma treatment system can aggravate asthma, especially in people 
with obesity.The study found that the weight of the obesity asthma group was 20% greater than ordinary 
mice but suffered from asthma. Asthma-obese mice have higher glucose, lipid and leptin levels. Symptoms 
of the obese asthma group are more severe than the normal asthma the obecity in asthma  has moresevere 
airway inflammation and structural changes, this clearly shows that obesity increases the severity of 
asthma. In addition, the obese asthma group has a higher percentage of neutrophils and the percentage of 
macrophages is lower than the asthma group. These results are influenced by higher levels of detection of 
leptin levels [F. Rusconi, Tomita. 2019) Leptin is a pleiotropic hormone and also has proinflammatory 
effects involved in regulating the immune response. Recent studies have shown that leptin is involved in 
the severity of asthma [J.Y. Kim, J.H et al 2014].  
Leptin is positively correlated with total body fat mass and may also play an important role in the 
pathogenesis of asthma. Leptin, a fat originally identified as a hormone released by adipocytes and 
positively correlated with total body fat mass [Westergren T 2014]. As an adipose signal, an increase in 
leptin levels means excess lipid storage, which is involved in modulating energy balance and limiting 
excess fat accumulation [L. Zhu, X. Chen et al, 2019]. Dill reported that leptin can increase leukotriene 
synthesis in alveolar macrophages, and leukotrienes play a central role in the pathophysiology of asthma, 
which implies that leptin may be involved in the occurrence and development of asthma. This finding 
suggests that leptin is associated with asthma, and can serve as a link between obesity and asthma [Abd 
El-Kader MS, et al. 2013, Chen Z, et al. 2017, Westergren T 2014] Treatment in obese asthmatics should 
pay attention to related causes such as excessive levels of leptin. A study shows that obesity increases 
asthma severity, and asthma obesity is a phenotype of refractory asthma [Gibeon D,et al 2013 & V. 
Hjellvik, A. Tverdal 2014] Refractory asthma patients are usually treated with systemic glucocorticoids or 
dexamethasone in clinical applications. But in obese asthma individuals, the study found that 
dexamethasone only suppressed airway inflammation, and did not have an effect on airway repair. In 
addition, obese asthmatics treated with dexamethasone will increase glucose, lipid and neutrophil levels so 
that they will worsen metabolic disorders and cause bad side effects. These findings suggest that obesity 
asthma may be an SR asthma subtype and responds poorly to these two treatments [Ostrom NK, et al 2019] 
Conversely, simvastatin can increase metabolic disorders, and suppress inflammatory airways and re- 
formation. In addition, compared with dexamethasone, simvastatin treatment reduces the percentage of 
leptin. These results indicate that simvastatin is effective in the treatment of obesity asthma. Correlation 
analysis showed that there was a positive correlation between the percentage of neutrophils and serum 
statin levels which showed that the efficacy of the therapy of simvastatin in obesity asthma with decreased 
levels of leptin [Van Leeuwen JC et al, 2014] 
 
5. Conclusion 
Obesity causes an increased risk of asthma and the severity of respiratory symptoms by reduced lung 
function or airway hyperreactivity (AHR), although it contributes to the more difficult to control asthma 
individuals it is important to consider that in clinical management, obese individuals are encouraged to 
lose weight. Weight loss can improve lung function, reduce the possibility of asthma, and improve overall 
health status. For this reason, in order to reduce the number of obese asthma, it is recommended to control 
quality of life such as diet, food intake and increase physical activity. Appropriate treatment techniques for 
individuals suffering from acid obesity can be done through simvastatin therapy and increased body 
adiponectin. 
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